Correlation Between Medical Equipment and Biotechnology Portfolio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medical Equipment and Biotechnology Portfolio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medical Equipment and Biotechnology Portfolio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medical Equipment And and Biotechnology Portfolio Biotechnology, you can compare the effects of market volatilities on Medical Equipment and Biotechnology Portfolio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medical Equipment with a short position of Biotechnology Portfolio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medical Equipment and Biotechnology Portfolio.

Diversification Opportunities for Medical Equipment and Biotechnology Portfolio

0.25
  Correlation Coefficient

Modest diversification

The 3 months correlation between Medical and Biotechnology is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Medical Equipment And and Biotechnology Portfolio Biotec in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Biotechnology Portfolio and Medical Equipment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medical Equipment And are associated (or correlated) with Biotechnology Portfolio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Biotechnology Portfolio has no effect on the direction of Medical Equipment i.e., Medical Equipment and Biotechnology Portfolio go up and down completely randomly.

Pair Corralation between Medical Equipment and Biotechnology Portfolio

Assuming the 90 days horizon Medical Equipment And is expected to generate 0.63 times more return on investment than Biotechnology Portfolio. However, Medical Equipment And is 1.58 times less risky than Biotechnology Portfolio. It trades about 0.09 of its potential returns per unit of risk. Biotechnology Portfolio Biotechnology is currently generating about 0.01 per unit of risk. If you would invest  6,624  in Medical Equipment And on September 3, 2024 and sell it today you would earn a total of  294.00  from holding Medical Equipment And or generate 4.44% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Medical Equipment And  vs.  Biotechnology Portfolio Biotec

 Performance 
       Timeline  
Medical Equipment And 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Medical Equipment And are ranked lower than 7 (%) of all funds and portfolios of funds over the last 90 days. In spite of fairly strong technical and fundamental indicators, Medical Equipment is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.
Biotechnology Portfolio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Biotechnology Portfolio Biotechnology has generated negative risk-adjusted returns adding no value to fund investors. In spite of fairly strong basic indicators, Biotechnology Portfolio is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Medical Equipment and Biotechnology Portfolio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medical Equipment and Biotechnology Portfolio

The main advantage of trading using opposite Medical Equipment and Biotechnology Portfolio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medical Equipment position performs unexpectedly, Biotechnology Portfolio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Biotechnology Portfolio will offset losses from the drop in Biotechnology Portfolio's long position.
The idea behind Medical Equipment And and Biotechnology Portfolio Biotechnology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets